Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury

Neuron

Volumn 44, Issue 3, 2004, Pages 439-451

  Kim, Ji Eun ^a   Liu, Betty P ^a   Park, James H ^a   Strittmatter, Stephen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; PROTEIN INHIBITOR; PROTEIN NOGO; RECEPTOR; RECEPTOR NOGO 66; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MOUSE; FEMALE; KNOCKOUT MOUSE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL TRACT; RAPHE NUCLEUS; RECEPTOR BINDING; RUBROSPINAL TRACT; SIGNAL TRANSDUCTION; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; SPINAL CORD TRANSSECTION; SPINAL GANGLION;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; AXONS; BEHAVIOR, ANIMAL; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BRAIN; CELL COUNT; CELLS, CULTURED; CLONING, MOLECULAR; DESIPRAMINE; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, MOTOR; FEMALE; GANGLIA, SPINAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GROWTH CONES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MYELIN PROTEINS; MYELIN SHEATH; NERVE REGENERATION; NEURONS; PHOSPHOLIPID ETHERS; PROTEINS; PYRAMIDAL TRACTS; RECEPTORS, CELL SURFACE; RECOVERY OF FUNCTION; SEROTONIN; SEROTONIN AGENTS; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS;

EID: 7044246002     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2004.10.015     Document Type: Article

References (30)

1. Antri M., Orsal D., Barthe J.Y. Locomotor recovery in the chronic spinal rat. effects of long-term treatment with a 5-HT2 agonist Eur. J. Neurosci. 16:2002;467-476
2. Barton W.A., Liu B.P., Tzvetkova D., Jeffrey P.D., Fournier A.E., Sah D., Cate R., Strittmatter S.M., Nikolov D.B. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J. 22:2003;3291-3302
3. Bartsch U., Bandtlow C.E., Schnell L., Bartsch S., Spillmann A.A., Rubin B.P., Hillenbrand R., Montag D., Schwab M.E., Schachner M. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron. 15:1995;1375-1381
4. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139:1996;244-256
5. Bonilla I.E., Tanabe K., Strittmatter S.M. Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J. Neurosci. 22:2002;1303-1315
6. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501
7. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22:2002;6570-6577
8. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35:2002;283-290
9. Doster S.K., Lozano A.M., Aguayo A.J., Willard M.B. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 6:1991;635-647
10. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346. a
11. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346. b
12. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444
13. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551
14. Huber A.B., Weinmann O., Brosamle C., Oertle T., Schwab M.E. Patterns of nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22:2002;3553-3567
15. Joshi M., Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse. Part 1. Clip design, behavioral outcomes, and histopathology J. Neurotrauma. 19:2002;175-190
16. Kim J.E., Bonilla I.E., Qiu D., Strittmatter S.M. Nogo-C is sufficient to delay nerve regeneration. Mol. Cell. Neurosci. 23:2003;451-459. a
17. Kim J.E., Li S., GrandPre T., Qiu D., Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron. 38:2003;187-199. b
18. Lauren J., Airaksinen M.S., Saarma M., Timmusk T. Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems. Mol. Cell. Neurosci. 24:2003;581-594
19. Leblond H., L'Esperance M., Orsal D., Rossignol S. Treadmill locomotion in the intact and spinal mouse. J. Neurosci. 23:2003;11411-11419
20. Li S., Strittmatter S.M. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23:2003;4219-4227
21. Liu B.P., Fournier A., GrandPre T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 297:2002;1190-1193
22. McGee A.W., Strittmatter S.M. The Nogo-66 receptor. focusing myelin inhibition of axon regeneration Trends Neurosci. 26:2003;193-198
23. Saruhashi Y., Young W. Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats. Exp. Neurol. 129:1994;207-216
24. Saruhashi Y., Young W., Perkins R. The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Exp. Neurol. 139:1996;203-213
25. Schmidt B.J., Jordan L.M. The role of serotonin in reflex modulation and locomotor rhythm production in the mammalian spinal cord. Brain Res. Bull. 53:2000;689-710
26. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron. 38:2003;201-211
27. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944. a
28. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22:2002;5505-5515. b
29. Woolf C.J. No Nogo. now where to go? Neuron. 38:2003;153-156
30. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron. 38:2003;213-224